18265-Lymphomas-NA-547

Lymphomas

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number:

  • Address

310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500

Search by practice name, trial titles, indicators and specific disease types.